Literature DB >> 24920160

Granulocyte colony-stimulating factor does not promote neurogenesis after experimental intracerebral haemorrhage.

Bernd Kallmünzer1, Miyuki Tauchi, Johannes C Schlachetzki, Kristin Machold, Ariana Schmidt, Jürgen Winkler, Stefan Schwab, Rainer Kollmar.   

Abstract

BACKGROUND: Hematopoietic growth factors have been suggested to induce neuroprotective and regenerative effects in various animal models of cerebral injury. However, the pathways involved remain widely unexplored. AIMS: This study aimed to investigate effects of local and systemic administration of granulocyte colony-stimulating factor on brain damage, functional recovery, and cerebral neurogenesis in an intracerebral haemorrhage whole blood injection model in rats.
METHODS: Eight-week-old male Wistar rats (n = 100) underwent induction of striatal intracerebral haemorrhage by autologous whole blood injection or sham procedure and were randomly assigned to either (a) systemic treatment with granulocyte colony-stimulating factor (60 μg/kg) for five-days; (b) single intracerebral injection of granulocyte colony-stimulating factor (60 μg/kg) into the cavity; or (c) application of vehicle for five-days. Bromodeoxyuridine-labelling and immunohistochemistry were used to analyze proliferation and survival of newly born cells in the sub-ventricular zone and the hippocampal dentate gyrus. Moreover, functional deficits and lesion volume were assessed until day 42 after intracerebral haemorrhage.
RESULTS: Differences in lesion size or hemispheric atrophy between granulocyte colony-stimulating factor-treated and control groups did not reach statistical significance. Neither systemic, nor local granulocyte colony-stimulating factor administration induced neurogenesis within the dentate gyrus or the sub-ventricular zone. The survival of newborn cells in these regions was prevented by intracerebral granulocyte colony-stimulating factor application. A subtle benefit in functional recovery at day 14 after intracerebral haemorrhage induction was observed after granulocyte colony-stimulating factor treatment.
CONCLUSION: There was a lack of neuroprotective or neuroregenerative effects of granulocyte colony-stimulating factor in the present rodent model of intracerebral haemorrhage. Conflicting results from functional outcome assessment require further research.
© 2013 The Authors. International Journal of Stroke © 2013 World Stroke Organization.

Entities:  

Keywords:  acute stroke therapy; brain bleed; cerebral haemorrhage; neuroprotection; stem cells; stroke

Mesh:

Substances:

Year:  2013        PMID: 24920160     DOI: 10.1111/ijs.12217

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  4 in total

1.  Effects of human umbilical cord mesenchymal stem cell transplantation combined with minimally invasive hematoma aspiration on intracerebral hemorrhage in rats.

Authors:  Qinghua Zhang; Xiao Shang; Maolin Hao; Maoyong Zheng; Yanxia Li; Zhigang Liang; Yuanxiao Cui; Zhenhua Liu
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

2.  Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro.

Authors:  Elena Redondo-Castro; Catriona Cunningham; Jonjo Miller; Licia Martuscelli; Sarah Aoulad-Ali; Nancy J Rothwell; Cay M Kielty; Stuart M Allan; Emmanuel Pinteaux
Journal:  Stem Cell Res Ther       Date:  2017-04-17       Impact factor: 6.832

3.  Systemic Factors Trigger Vasculature Cells to Drive Notch Signaling and Neurogenesis in Neural Stem Cells in the Adult Brain.

Authors:  Ruihe Lin; Jingli Cai; Lawrence Kenyon; Renato Iozzo; Robert Rosenwasser; Lorraine Iacovitti
Journal:  Stem Cells       Date:  2018-12-30       Impact factor: 6.277

Review 4.  The role of G-CSF neuroprotective effects in neonatal hypoxic-ischemic encephalopathy (HIE): current status.

Authors:  John Sieh Dumbuya; Lu Chen; Jang-Yen Wu; Bin Wang
Journal:  J Neuroinflammation       Date:  2021-02-21       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.